MetLife Investment Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-170
| Closed | -$157K | – | 2418 |
|
2019
Q2 | $157K | Hold |
170
| – | – | ﹤0.01% | 2168 |
|
2019
Q1 | $272K | Hold |
170
| – | – | ﹤0.01% | 1812 |
|
2018
Q4 | $319K | Hold |
170
| – | – | ﹤0.01% | 1638 |
|
2018
Q3 | $402K | Hold |
170
| – | – | ﹤0.01% | 1668 |
|
2018
Q2 | $587K | Hold |
170
| – | – | 0.01% | 1311 |
|
2018
Q1 | $484K | Hold |
170
| – | – | 0.01% | 1388 |
|
2017
Q4 | $439K | Buy |
+170
| New | +$439K | 0.01% | 1472 |
|